Engineered Extracellular Vesicles in Arthritic Diseases: Therapeutic Applications & Challenges
WIREs Nanomedicine and Nanobiotechnology · 2025-07 · 17 (4)
DOI: 10.1002/wnan.70031 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift WIREs Nanomedicine and Nanobiotechnology, online erschienen am 19.08.2025. Verfasst von Seif Ehab und 5 weiteren Autor:innen. Beteiligte Einrichtung: Biomedical Sciences Program, University of Science and Technology, Zewail City of Science and Technology, Giza, Egypt. Hauptthemen laut MEDLINE: Extracellular Vesicles, Osteoarthritis. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 309 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Arthritic diseases are a significant global health challenge, highlighting the urgent need for innovative therapeutic strategies. Extracellular vesicles (EVs) have emerged as promising candidates for treating various intractable diseases. This review explores the therapeutic potential of engineered EVs in joint diseases, particularly in comparison to their parental stem cells. Recent research underscores the efficacy of EVs in treating joint diseases, especially Osteoarthritis (OA). We discuss EV engineering strategies aimed at overcoming the limitations of natural EVs. Data from preclinical trials, clinical studies, and in vitro and in vivo reports are analyzed to evaluate the effectiveness of EVs in treating joint conditions. In addition to their role in intercellular communication, EVs influence various biological processes crucial for bone remodeling, cartilage regeneration, immunomodulation, and inflammation control. EVs are rich in vital biomolecules such as proteins, microRNAs (miRNA), lipids, and nucleic acids, which enhance their therapeutic potential compared to parental stem cells. This understanding is key to developing targeted and effective engineered EVs for OA and other joint diseases. A comprehensive grasp of EV engineering and underlying mechanisms will pave the way for novel and efficient therapies for arthritic diseases and related conditions. This article is categorized under: Implantable Materials and Surgical Technologies > Nanotechnology in Tissue Repair and Replacement Nanotechnology Approaches to Biology > Cells at the Nanoscale Biology‐Inspired Nanomaterials > Peptide‐Based Structures
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Biomedical Sciences Program, University of Science and Technology, Zewail City of Science and Technology, Giza, Egypt.
- Wake Forest Institute for Regenerative Medicine, Wake Forest School of Medicine, Winston Salem, USA.
- Department of Biology, Faculty of Science, University of Tabuk, Tabuk, Saudi Arabia.
- Department of Medical Laboratory Technology, College of Nursing and Health Sciences, Jazan University, Jazan, Saudi Arabia.
- Emerging and Endemic Infectious Diseases Research Unit, Health Sciences Research Center, Jazan University, Jazan, Saudi Arabia.
- King Fahd Medical Research Center, Embryonic Stem Cells Unit, Department of Biochemistry, Faculty of Science, King AbdulAziz University, Jeddah, Saudi Arabia.
ORCID-Profile: Seif Ehab, Ola A Gaser, Atif Abdulwahab A Oyouni, Nader Kameli, Faisal Alzahrani, Ahmed Abdal Dayem
Zitieren
APA
Ehab, S., Gaser, O. A., Oyouni, A. A. A., Kameli, N., Alzahrani, F., & Abdal Dayem, A. (2025). Engineered Extracellular Vesicles in Arthritic Diseases: Therapeutic Applications & Challenges. WIREs Nanomedicine and Nanobiotechnology, 17(4). https://doi.org/10.1002/wnan.70031
Vancouver
Ehab S, Gaser OA, Oyouni AAA, Kameli N, Alzahrani F, Abdal Dayem A. Engineered Extracellular Vesicles in Arthritic Diseases: Therapeutic Applications & Challenges. WIREs Nanomedicine and Nanobiotechnology. 2025;17(4). doi:10.1002/wnan.70031
BibTeX
@article{Ehab2025,
author = {Ehab, Seif and Gaser, Ola A and Oyouni, Atif Abdulwahab A and Kameli, Nader and Alzahrani, Faisal and Abdal Dayem, Ahmed},
title = {Engineered Extracellular Vesicles in Arthritic Diseases: Therapeutic Applications & Challenges},
journal = {WIREs Nanomedicine and Nanobiotechnology},
year = {2025},
volume = {17},
number = {4},
doi = {10.1002/wnan.70031}
}
EUVIMED